| Seq Identity | Jmol Display | PDB Title |
---|
2IEN | 100% | | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) |
---|
3TKW | 100% | | CRYSTAL STRUCTURE OF HIV PROTEASE MODEL PRECURSOR/DARUNAVIR COMPLEX |
---|
3CYW | 99% | | EFFECT OF FLAP MUTATIONS ON STRUCTURE OF HIV-1 PROTEASE AND INHIBITION BY SAQUINAVIR AND DARUNAVIR |
---|
2F80 | 99% | | HIV-1 PROTEASE MUTANT D30N COMPLEXED WITH INHIBITOR TMC114 |
---|
3PWM | 99% | | HIV-1 PROTEASE MUTANT L76V WITH DARUNAVIR |
---|
2IEO | 99% | | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) |
---|
3D20 | 99% | | CRYSTAL STRUCTURE OF HIV-1 MUTANT I54V AND INHIBITOR DARUNAVIA |
---|
2IDW | 99% | | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) |
---|
2HS1 | 99% | | ULTRA-HIGH RESOLUTION X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE V32I MUTANT WITH TMC114 (DARUNAVIR) INHIBITOR |
---|
2HS2 | 99% | | CRYSTAL STRUCTURE OF M46L MUTANT OF HIV-1 PROTEASE COMPLEXED WITH TMC114 (DARUNAVIR) |
---|
2F8G | 99% | | HIV-1 PROTEASE MUTANT I50V COMPLEXED WITH INHIBITOR TMC114 |
---|
2F81 | 99% | | HIV-1 PROTEASE MUTANT L90M COMPLEXED WITH INHIBITOR TMC114 |
---|
3BVB | 99% | | CYSTAL STRUCTURE OF HIV-1 ACTIVE SITE MUTANT D25N AND INHIBITOR DARUNAVIR |
---|
3D1Z | 99% | | CRYSTAL STRUCTURE OF HIV-1 MUTANT I54M AND INHIBITOR DARUNAVIR |
---|
3JW2 | 99% | | HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR |
---|
5KQY | 98% | | PROTEASE E35D-DRV |
---|
4DQB | 97% | | CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH DRV |
---|
3S53 | 97% | | HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG DARUNAVIR IN SPACE GROUP P212121 |
---|
3S54 | 97% | | HIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG DARUNAVIR IN SPACE GROUP P21212 |
---|
5E5J | 97% | | JOINT X-RAY/NEUTRON STRUCTURE OF HIV-1 PROTEASE TRIPLE MUTANT (V32I, I47V,V82I) WITH DARUNAVIR AT PH 6.0 |
---|
5E5K | 97% | | JOINT X-RAY/NEUTRON STRUCTURE OF HIV-1 PROTEASE TRIPLE MUTANT (V32I, I47V,V82I) WITH DARUNAVIR AT PH 4.3 |
---|
4DQH | 96% | | CRYSTAL STRUCTURE OF (R14C/E65C) HIV-1 PROTEASE IN COMPLEX WITH DRV |
---|
4DQE | 95% | | CRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX WITH DRV |
---|
4DQF | 95% | | CRYSTAL STRUCTURE OF (G16A/L38A) HIV-1 PROTEASE IN COMPLEX WITH DRV |
---|
4DQC | 95% | | CRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX WITH DRV |
---|
6OPS | 95% | | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH DARUNAVIR |
---|
6DGX | 95% | | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH DARUNAVIR |
---|
4HLA | 95% | | CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH DARUNAVIR |
---|
4LL3 | 94% | | STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH DARUNAVIR |
---|
6DH3 | 94% | | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 V82I MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6DH0 | 94% | | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6DH6 | 94% | | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 I50V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
5KR1 | 94% | | PROTEASE PR5-DRV |
---|
6OOU | 94% | | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 L89V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6OOS | 94% | | HIV-1 PROTEASE NL4-3 L90M MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6OPT | 93% | | HIV-1 PROTEASE NL4-3 V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6OOT | 93% | | HIV-1 PROTEASE NL4-3 L89V, L90M MUTANT IN COMPLEX WITH DARUNAVIR |
---|
3OY4 | 92% | | CRYSTAL STRUCTURE OF HIV-1 L76V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR. |
---|
4Q1Y | 92% | | MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE |
---|
4Q1X | 92% | | MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE |
---|
4Q1W | 92% | | MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE |
---|
1T7I | 92% | | THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR. |
---|
1T3R | 92% | | HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR |
---|
6OPU | 91% | | HIV-1 PROTEASE NL4-3 K45I, M46I, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
3OXW | 90% | | CRYSTAL STRUCTURE OF HIV-1 I50V, A71V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR |
---|
7MAS | 90% | | DRUG RESISTANT HIV-1 PROTEASE (L10F, M46I, I50V, F53L, L63P, G73S) IN COMPLEX WITH DRV |
---|
7MAQ | 89% | | DRUG RESISTANT HIV-1 PROTEASE (L10F, V32I, L33F, K45I, A71V, V82I, I84V) IN COMPLEX WITH DRV |
---|
3LZS | 89% | | CRYSTAL STRUCTURE OF HIV-1 CRF01_AE PROTEASE IN COMPLEX WITH DARUNAVIR |
---|
3EKT | 89% | | CRYSTAL STRUCTURE OF THE INHIBITOR DARUNAVIR (DRV) IN COMPLEX WITH A MULTI-DRUG RESISTANT HIV-1 PROTEASE VARIANT (L10F/G48V/I54V/V64I/V82A) (REFER: FLAP+ IN CITATION.) |
---|
6OPV | 88% | | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
3LZU | 88% | | CRYSTAL STRUCTURE OF A NELFINAVIR RESISTANT HIV-1 CRF01_AE PROTEASE VARIANT (N88S) IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR. |
---|
7MAP | 87% | | DRUG RESISTANT HIV-1 PROTEASE (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) IN COMPLEX WITH DRV |
---|
6OPW | 87% | | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6OPX | 87% | | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
6OPY | 86% | | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR |
---|
4NPT | 86% | | CRYSTAL STRUCTURE OF HIV-1 PROTEASE MULTIPLE MUTANT P51 COMPLEXED WITH DARUNAVIR |
---|